Jiangsu Nhwa Pharmaceutical Co., Ltd. Jiangsu Nhwa Pharmaceutical Co., Ltd.

Jiangsu Nhwa Pharmaceutical Co., Ltd.

002262

Classifica tra le azioni #4690
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Prezzo delle azioni
$3.18
Capitalizzazione di mercato
$3.22B
Variazione (1 giorno)
0.97%
Variazione (1 anno)
-13.18%
Paese
CN
Scambia Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)

Categoria

Healthcare
Rapporto P/B per Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Rapporto P/B al October 2026 TTM: 2.55
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Jiangsu Nhwa Pharmaceutical Co., Ltd., il rapporto P/B attuale (TTM) è 2.55. Alla fine del 2023, era pari a 4.30.
Storico del rapporto P/B per Jiangsu Nhwa Pharmaceutical Co., Ltd. da 2005 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
2026 (TTM) 2.55 -24.63%
2024 3.38 -21.41%
2023 4.30 -2.38%
2022 4.40 37.29%
2021 3.20 -18.27%
2020 3.92 20.59%
2019 3.25 9.26%
2018 2.98 -47.37%
2017 5.65 -10.10%
2016 6.29 -18.49%
2015 7.72 -17.46%
2014 9.35 -15.16%
2013 11.02 47.24%
2012 7.48 30.38%
2011 5.74 -33.54%
2010 8.64 39.42%
2009 6.19 73.28%
2008 3.58 -72.45%
2007 12.98 12.26%
2006 11.56 24.47%
2005 9.29 0.00%
Rapporto P/B per aziende simili o concorrenti